Evidence map›Paper›PMID 34786354›Full record

ArticleAnnals of global health2021

COVID-19 Vaccines: Ensuring Social Justice and Health Equity among Refugees in Africa.

Emery Manirambona, Oliver Hague, Luiza Farache Trajano, Annabel Killen, Laura Wilkins, Menelas Nkeshimana, Don Eliseo Lucero-Prisno Iii

Abstract read
In one paragraph

Article in Annals of global health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Emery ManirambonaCollege of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda.ORCID 0000-0002-0579-3607
Oliver HagueMedical Sciences Division, University of Oxford, Oxford, United Kingdom.ORCID 0000-0003-2644-9191
Luiza Farache TrajanoMedical Sciences Division, University of Oxford, Oxford, United Kingdom.ORCID 0000-0003-0401-3426
Annabel KillenMedical Sciences Division, University of Oxford, Oxford, United Kingdom.ORCID 0000-0002-8125-5544
Laura WilkinsMedical Sciences Division, University of Oxford, Oxford, United Kingdom.ORCID 0000-0003-1562-8688
Menelas NkeshimanaDepartment of Anesthesia, Emergency Medicine and Critical Care, Centre Hospitalier Universitaire de Kigali and University of Rwanda, Kigali, Rwanda.ORCID 0000-0003-3573-8075
Don Eliseo Lucero-Prisno IiiDepartment of Global Health and Development, London School of Hygiene and Tropical Medicine, London, United Kingdom.ORCID 0000-0002-2179-6365

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 poses a particular threat to refugees in Africa. Overcrowded living conditions and lack of effective sanitation make refugees highly vulnerable to infection. Furthermore, migration has the potential to undermine measures to control viral spread. As a result, vaccination of the refugee community in Africa must be considered key in the vaccination plan to end the worldwide COVID-19 pandemic. Although the WHO has approved vaccines for emergency use worldwide in vulnerable groups through the COVID-19 Vaccines Global Access (COVAX) program, there is a lack of a strategy for achieving vaccination in the African refugee population. A specific strategy for refugee vaccination must be among the top priorities at national, regional, and global levels to ensure all refugees and asylum seekers in African countries have equitable and quality vaccine assistance regardless of displacement, statelessness, and financial hardship. We call on leaders in Africa and worldwide to ensure that refugee vaccination is a priority to protect this highly at-risk population and achieve an end to the current pandemic.

Indexed as

COVID-19Health EquityRefugeesAfricaCOVID-19 VaccinesHumansPandemicsSARS-CoV-2Social JusticeCOVID-19 Vaccines

Identifiers

PMID34786354
PMCPMC8570198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.